MassIVE MSV000098124

Partial Public PXD064888

Virus glycoprotein nanodisc assembly platform for vaccine design

Subscribe Comment Convert Spectra Add Reanalysis

Description

Transmembrane glycoproteins of enveloped viruses play a critical role in initiating infection by binding to host cell receptors and mediating viral entry. These proteins are essential targets for vaccine development as antibodies elicited by natural infection or immunization can bind to and prevent the virus entry. mRNA-LNP technology now allows in situ production of transmembrane glycoproteins upon immunization, but biophysical characterization of novel immunogens and in vitro analysis of antibody responses post-immunization rely largely on soluble proteins. These are typically obtained by truncation of membrane-proximal, transmembrane, and intracellular domains. Here, we present a methodological platform for assembling transmembrane virus glycoprotein vaccine candidates into lipid nanodiscs. The platform enables the use of transmembrane glycoproteins in analytical methods traditionally employed for soluble immunogens. We demonstrate the utility of the assembled glycoprotein nanodiscs in HIV MPER-targeting vaccine development by performing kinetic binding assays using SPR, ex vivo B cell sorting with FACS, and by resolving the structure of a prototypical HIV MPER targeting immunogen nanodisc in complex with three neutralizing antibodies, including MPER targeting antibody 10E8 to 3.6 Angstrom. Overall, the platform offers a valuable tool for accelerating the rational design and optimization of next-generation viral vaccines. [doi:10.25345/C52805B4C] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: DeGlyPHER ; membrane glycoprotein ; lipid nanodisc ; site-specific N-glycosylation ; LNP mRNA vaccine ; HIV Env MPER ; enveloped virus spike protein ; DatasetType:Proteomics

Contact

Principal Investigators:
(in alphabetical order) 		John R. Yates III, The Scripps Research Institute, USA
Submitting User: sbaboo
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
Browse Quantification Results
 
FTP Download Link (click to copy):

Species

Instrument

Modifications

- Dataset Reanalyses

+ Dataset History

Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.